bioRxivCancer BiologyPreprint
Androgen receptor contributes to radioresistance through DNA repair and autophagy in AR-positive prostate cancer cells
Kenichi KudoiD, Qianhua FengiD, Maria Isabel ChoscoiD, Jonathan M. AnzulesiD, Ziyi HuangiD, Kavya AchantaiD, Leslie WenningiD, Jeshwanth Mohan, June‐Wha RheeiD, Maedeh MohebnasabiD, Evita T. SadiminiD, Zhao V. WangiD, Yun Rose LiiD
Abstract
Androgen receptor (AR) is a critical therapeutic target in prostate cancer (PCa), and androgen blockade is known to act synergistically with radiation therapy. However, the mechanisms through which AR modulates radiation response are not yet fully understood. In this study, we aimed to investigate the role of AR in mediating radioresistance in PCa. AR-positive LNCaP and castration-resistant C4-2 cells exhibited significantly higher radioresistance than AR-negative cells, as determined by apoptosis and cell viability assays. Following irradiation, most LNCaP cells were arrested in the G1 phase, accompanied by rapid p53 activation and p21 induction. Consistently, AR silencing significantly increased radiosensitivity and reduced DNA-PKcs expression and phosphorylation, suggesting that AR enhances DNA repair, likely through non-homologous end joining (NHEJ). At the cellular level, irradiation markedly induced macroautophagy in LNCaP and C4-2 cells, as evidenced by increased LC3B-II accumulation and autophagic vacuole formation, and the upregulation of 11 autophagy-related genes was identified by whole-transcriptomic analysis. To assess their functional relevance, we performed siRNA-mediated knockdown of selected autophagy-related genes and assessed cell viability and Annexin V/PI staining. Notably, BECN1 and LC3 knockdown significantly enhanced radiosensitivity, with BECN1 knockdown showing an effect comparable to that observed with AR silencing. These results suggest that radiation-induced autophagy promotes the survival of AR-positive prostate cancer cells. Moreover, immunohistochemical analysis of ex vivo-irradiated, patient-derived PCa tissues from patients with newly diagnosed high-Gleason score prostate cancer undergoing prostatectomy further demonstrated that radiation-induced autophagy supports the survival of high-grade AR-positive tumor cells. Collectively, our findings reveal that AR promotes radioresistance in PCa by enhancing both DNA repair and autophagy. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=138 SRC="FIGDIR/small/690226v1_ufig1.gif" ALT="Figure 1"> View larger version (45K): org.highwire.dtl.DTLVardef@3f713corg.highwire.dtl.DTLVardef@1233a11org.highwire.dtl.DTLVardef@1b94e5eorg.highwire.dtl.DTLVardef@c8338c_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Androgen Receptor-Induced Integrin α6β1 and Adhesion to Laminin Promotes Survival andDrug Resistance in Castration-Resistant Prostate Cancer through BNIP3
Eric A. Nollet, Sourik S. Ganguly, … Cindy K. Miranti·bioRxiv·Jun 15, 2018
- Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade
M. Pinho-Schwermann, C. Purcell, … W. S. El-Deiry·bioRxiv·Nov 15, 2023
- Functionality of BRCA1 supports the survival of prostate cancer cells during the development of castration resistance
Saiganesh Sriraman, Verneri Virtanen, … Maria Sundvall·bioRxiv·Jun 19, 2024
- Radiopotentiation of Enzalutamide over Human Prostate Cancer Cells as Assessed by Real-Time Cell Monitoring
M. Barrado, I. Blanco-Luquin, … F. Arias·bioRxiv·May 17, 2018
- Arrested Agonist Paradigm For Selective Radiosensitization of Prostate Cancer
J. B. Coulter, M. Haffner, … S. Yegnasubramanian·bioRxiv·Oct 1, 2023
- AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M. McNair, … Ayesha A. Shafi·OncogenePeer-reviewed·Sep 12, 2024